Imaging Brain Phospholipase A2-Mediated Signal Transduction in Response to Acute Fluoxetine Administration in Unanesthetized Rats

Fluoxetine, a selective serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibitor, is used widely to treat depression and related disorders. By inhibiting presynaptic 5-HT reuptake, fluoxetine is thought to act by increasing 5-HT in the synaptic cleft, thus 5-HT binding to postsynaptic 5-HT2A/2C receptors. These receptors can be coupled via a G-protein to phospholipase A2 (PLA2), which when activated releases the second messenger arachidonic acid from synaptic membrane phospholipids. To image this activation, fluoxetine (10 mg/kg) or saline vehicle was administered i.p. to unanesthetized rats, and regional brain incorporation coefficients k* of intravenously injected radiolabeled arachidonic acid were measured after 30 min. Compared with vehicle, fluoxetine significantly increased k* in prefrontal, motor, somatosensory, and olfactory cortex, as well as in the basal ganglia, hippocampus, and thalamus. Many of these regions demonstrate high densities of the serotonin reuptake transporter and of 5-HT2A/2C receptors. Brain stem, spinal cord, and cerebellum, which showed no significant response to fluoxetine, have low densities of the transporters and receptors. The results show that it is possible to image quantitatively PLA2-mediated signal transduction in vivo in response to fluoxetine.

[1]  C. Leslie,et al.  Cytosolic phospholipase A2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism. , 1997, The Biochemical journal.

[2]  L. Sokoloff.  Energetics of Functional Activation in Neural Tissues , 1999, Neurochemical Research.

[3]  K. Perry,et al.  Extracellular 5‐hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus l‐5‐hydroxytryptophan , 1993, The Journal of pharmacy and pharmacology.

[4]  早川 隆宣,et al.  Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease , 2004 .

[5]  Fluoxetine effects on cerebral glucose metabolism. , 1994, Neuroreport.

[6]  R. Fuller,et al.  Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. , 1995, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[7]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[8]  G. Battaglia,et al.  Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats , 1993, Brain Research.

[9]  D. Wong,et al.  Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. , 1995, Life sciences.

[10]  F. Fitzpatrick,et al.  Regulated formation of eicosanoids. , 2001, The Journal of clinical investigation.

[11]  B. Roth,et al.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor , 1996, Psychopharmacology.

[12]  S. Rapoport,et al.  Regional cerebral incorporation of plasma [14C]palmitate, and cerebral glucose utilization, in water-deprived Long-Evans and Brattleboro rats , 1989, Experimental Neurology.

[13]  M. Dam,et al.  Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies , 2000, Brain Research.

[14]  D. Wong,et al.  Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[15]  S. Rapoport,et al.  A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis , 1992, Brain Research Reviews.

[16]  K. Nisijima,et al.  Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex , 2002, Neurochemistry International.

[17]  Floyd E. Bloom,et al.  The biochemical basis of neuropharmacology, 8th ed. , 2003 .

[18]  F. Bloom,et al.  The Biochemical Basis of Neuropharmacology , 1976 .

[19]  F. Artigas,et al.  Role of uptake inhibition and autoreceptor activation in the control of 5‐HT release in the frontal cortex and dorsal hippocampus of the rat , 2000, British journal of pharmacology.

[20]  D. Wong,et al.  Inhibition of serotonin reuptake. , 1977, Federation proceedings.

[21]  J. Axelrod,et al.  Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. , 1990, Biochemical Society transactions.

[22]  S. Rapoport,et al.  Energy requirements for two aspects of phospholipid metabolism in mammalian brain. , 1998, The Biochemical journal.

[23]  R. Glennon,et al.  Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.

[24]  T. Dinan.  Serotonin: current understanding and the way forward , 1996, International clinical psychopharmacology.

[25]  F. Turkheimer,et al.  5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochlori , 2002, The Journal of pharmacology and experimental therapeutics.

[26]  G. Gerhardt,et al.  Acute locomotor effects of fluoxetine, sertraline, and nomifensine in young versus aged Fischer 344 rats , 2002, Pharmacology Biochemistry and Behavior.

[27]  C. Montigny,et al.  Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  F. Sun,et al.  Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease. , 1998, American journal of physiology. Cell physiology.

[29]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[30]  J W Dailey,et al.  Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. , 1992, The Journal of pharmacology and experimental therapeutics.

[31]  S. Rapoport,et al.  In Vivo Imaging of Fatty Acid Incorporation into Brain to Examine Signal Transduction and Neuroplasticity Involving Phospholipids , 1997, Annals of the New York Academy of Sciences.

[32]  S. Rapoport,et al.  Preferential In Vivo Incorporation of [3H]Arachidonic Acid from Blood into Rat Brain Synaptosomal Fractions Before and After Cholinergic Stimulation , 1996, Journal of neurochemistry.

[33]  Peter Herscovitch,et al.  Brain incorporation of [1–11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography , 1997, Brain Research.

[34]  E. sanders-Bush,et al.  Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[35]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[36]  T Nariai,et al.  Arecoline‐Stimulated Brain Incorporation of Intravenously Administered Fatty Acids in Unanesthetized Rats , 1991, Journal of neurochemistry.

[37]  G. Bagdy,et al.  Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. , 1999, Neuroreport.

[38]  J. Büttner-Ennever.  The Rat Brain in Stereotaxic Coordinates, 3rd edn. By George Paxinos and Charles Watson. (Pp. xxxiii+80; illustrated; £$69.95 paperback; ISBN 0 12 547623; comes with CD‐ROM.) San Diego: Academic Press. 1996. , 1997 .

[39]  S. Rapoport,et al.  Quantitative brain autoradiography of [9, 10‐3H]palmitic acid incorporation into brain lipids , 1990, Journal of neuroscience research.

[40]  G. Mickley,et al.  Brain hyperthermia alters local cerebral glucose utilization: a comparison of hyperthermic agents. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[41]  P. Fletcher,et al.  Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction , 1999, Psychopharmacology.

[42]  M. Kaufman,et al.  Serotonin 5‐HT2C Receptor Stimulates Cyclic GMP Formation in Choroid Plexus , 1995, Journal of neurochemistry.

[43]  S. Rapoport,et al.  Intravenously injected [1-14C]arachidonic acid targets phospholipids, and [1-14C]palmitic acid targets neutral lipids in hearts of awake rats , 2000, Lipids.

[44]  J. Meyer,et al.  Effects of prenatal cocaine exposure on serotonin and norepinephrine transporter density in the rat brain. , 1998, Annals of the New York Academy of Sciences.

[45]  P. Acton,et al.  Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain , 2000, Synapse.

[46]  B. Leonard.  Stress, norepinephrine and depression , 2002, Acta Neuropsychiatrica.

[47]  W. Mcbride,et al.  Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens , 1988, Brain Research Bulletin.

[48]  S. Rivest,et al.  Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain , 1998, Neuroscience.

[49]  M. Molliver,et al.  Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity , 2000, The Journal of Neuroscience.

[50]  J. Michenfelder.  Blood–Brain Barrier in Physiology and Medicine , 1977 .

[51]  S. Rapoport,et al.  Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats , 1991, Brain Research.

[52]  D. Piomelli,et al.  Dopamine D2 Receptors Potentiate Arachidonate Release via Activation of Cytosolic, Arachidonate‐Specific Phospholipase A2 , 1995, Journal of neurochemistry.

[53]  J. Meyer,et al.  Effects of Prenatal Cocaine Exposure on Serotonin and Norepinephrine Transporter Density in the Rat Brain a , 1998, Annals of the New York Academy of Sciences.

[54]  R. Lukas,et al.  Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function , 1999, Journal of neurochemistry.

[55]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[56]  P. Blier,et al.  Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder , 1999, Biological Psychiatry.

[57]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[58]  M. Raiteri,et al.  Presynaptic autoreceptors control serotonin release from central nerve endings. , 1980, Pharmacological research communications.

[59]  F. Zhou,et al.  Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence , 1998, Brain Research.

[60]  D. Murphy,et al.  Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists , 1997, Psychopharmacology.

[61]  E. Rüther,et al.  Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. , 2000, Brain research. Developmental brain research.

[62]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[63]  J. Axelrod,et al.  Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[65]  E. D. De Souza,et al.  Autoradiographic localization of 3H‐paroxetine‐labeled serotonin uptake sites in rat brain , 1987, Synapse.

[66]  H. Holloway,et al.  Methiothepin reduces glucose utilization in forebrain regions of awake rats , 2004, Psychopharmacology.

[67]  H. Y. Kim,et al.  The release of polyunsaturated fatty acids and their lipoxygenation in the brain. , 1999, Advances in experimental medicine and biology.

[68]  M. Kurt,et al.  The Effects of Sertraline and Fluoxetine on Anxiety in the Elevated Plus-Maze Test , 2000, Journal of basic and clinical physiology and pharmacology.

[69]  S B Auerbach,et al.  Acute uptake inhibition increases extracellular serotonin in the rat forebrain. , 1993, The Journal of pharmacology and experimental therapeutics.

[70]  R. Sapolsky,et al.  The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. , 1991, Endocrine reviews.

[71]  F. Chueh,et al.  Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function , 1998 .

[72]  J. D. Bell,et al.  Relationships between bilayer structure and phospholipase A2 activity: interactions among temperature, diacylglycerol, lysolecithin, palmitic acid, and dipalmitoylphosphatidylcholine. , 1996, Biochemistry.

[73]  K. Rasmussen,et al.  Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[74]  R. Kasser,et al.  Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex. , 1990, The Journal of pharmacology and experimental therapeutics.

[75]  G. Griebel,et al.  Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine , 1995, Psychopharmacology.

[76]  Andrea Balbo,et al.  Imaging Brain Phospholipase A2 Activation in Awake Rats in Response to the 5-HT2A/2C Agonist (±)2,5-Dimethoxy-4-Iodophenyl-2-Aminopropane (DOI) , 2003, Neuropsychopharmacology.